Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Receives $4.00 Average Target Price from Analysts

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) has been assigned an average recommendation of “Hold” from the five analysts that are presently covering the stock, MarketBeat reports. One analyst has rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating on the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $4.00.

Several research firms recently issued reports on BIOX. Canaccord Genuity Group reduced their price target on shares of Bioceres Crop Solutions from $2.25 to $2.00 and set a “hold” rating on the stock in a research report on Friday, January 2nd. Weiss Ratings restated a “sell (d-)” rating on shares of Bioceres Crop Solutions in a research note on Monday, December 29th. Finally, Wall Street Zen raised Bioceres Crop Solutions from a “sell” rating to a “hold” rating in a report on Saturday, November 22nd.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. Jones Financial Companies Lllp grew its stake in shares of Bioceres Crop Solutions by 3,535.8% during the first quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company’s stock worth $25,000 after buying an additional 5,339 shares during the last quarter. Bank of America Corp DE lifted its stake in shares of Bioceres Crop Solutions by 186.8% in the 4th quarter. Bank of America Corp DE now owns 5,735 shares of the company’s stock valued at $35,000 after acquiring an additional 3,735 shares during the last quarter. Virtu Financial LLC acquired a new stake in shares of Bioceres Crop Solutions during the 3rd quarter valued at $40,000. Invesco Ltd. acquired a new stake in shares of Bioceres Crop Solutions during the 4th quarter valued at $45,000. Finally, PDT Partners LLC grew its position in Bioceres Crop Solutions by 58.9% during the 2nd quarter. PDT Partners LLC now owns 28,180 shares of the company’s stock worth $126,000 after acquiring an additional 10,449 shares during the last quarter. Institutional investors own 17.68% of the company’s stock.

Bioceres Crop Solutions Price Performance

BIOX stock opened at $0.54 on Monday. The company’s 50-day moving average price is $0.92 and its two-hundred day moving average price is $1.50. The firm has a market cap of $33.87 million, a P/E ratio of -0.64 and a beta of 0.53. The company has a quick ratio of 0.64, a current ratio of 0.94 and a debt-to-equity ratio of 0.19. Bioceres Crop Solutions has a 12 month low of $0.40 and a 12 month high of $5.40.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.

Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.